Associate Director, Corporate Strategy

1 week ago


Redwood City, California, United States MapLight Therapeutics, Inc. Full time

Who We Are:
MapLight Therapeutics is a clinical stage biotech company that focuses on drug discovery for central nervous system disorders. We combine cutting-edge technologies including optogenetics, in vivo physiology, and spatial transcriptomics to identify novel drug targets and develop effective therapies to address psychiatric symptoms.

What You'll Do:
We are seeking a highly motivated and experienced Associate Director, Corporate Strategy to join our growing team. In this role, you will be a cross-functional partner in developing and executing the financial strategy and commercial planning. The ideal candidate will bring deep financial acumen, a strong understanding of biotech clinical and commercial process, and a collaborative, hands-on approach.

Responsibilities

  • Act as a strategic finance partner to Clinical Development, Medical Affairs, and other commercial and corporate functions, supporting integrated planning, resource allocation, and cross-functional alignment
  • Provide financial insights for program reviews, portfolio prioritization, business development opportunities, and other strategic decision-making discussions
  • Support clinical and commercial planning through primary and secondary research
  • Integrate competitive intelligence and market analytics into financial modeling by translating external landscape insights into actionable planning assumptions
  • Develop long-range planning models, program-level forecasts, and valuation frameworks to assess pipeline potential, launch readiness, and other investment decisions
  • Support resource planning in partnership with functional leaders to support program execution and organizational scaling
  • Create dashboards and data visualizations to track KPIs, development progress, and resource utilization
  • Assist with board presentations, investor materials, and other executive communications
  • Contribute to the optimization of finance systems and tools (e.g., NetSuite, Adaptive Insights, Coupa) to enhance planning accuracy, efficiency, and scalability
  • Help establish the financial infrastructure, tools, and processes needed to support MapLight's growth

Qualifications

  • Bachelor's degree in Finance, Accounting, Economics, or related field; Master's degree preferred
  • 8+ years of progressive experience in FP&A, strategic finance, or corporate planning
  • Demonstrated ability to build dynamic financial models and conduct scenario planning to support pipeline valuation and investment decisions
  • Strong understanding of the biotech development and commercialization lifecycle, including key drivers such as pricing, market access, and program cost structures
  • Experience translating scientific and market insights into strategic financial implications; exposure to competitive intelligence or portfolio planning is a plus
  • Proficiency in financial systems (e.g., NetSuite, Adaptive Insights, Anaplan, Tableau, Excel)
  • Excellent communication and interpersonal skills, with the ability to partner cross-functionally and influence stakeholders at all levels
  • Comfortable operating in a fast-paced, pre-commercial or high-growth biotech environment with evolving processes
  • Highly organized, analytical, and capable of managing multiple priorities independently

Location:
This is a hybrid role on-site 3 days per week in our offices in Redwood City, CA or Burlington, MA.

Travel
Ability to travel as needed (up to 20%) for corporate and department-wide meetings.

Compensation for this role may vary within the above range based on many factors including geographic location, candidate experience, and skills. Additional compensation/benefits include annual bonus opportunity, medical, dental, vision, life and AD&D, short term and long term disability, 401(K) plan with match, stock options, flexible non-accrual paid time off, and parental leave.

Salary Range

$190,000—$215,000 USD

EEOC Statement: MapLight Therapeutics is an equal opportunity employer, and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, sexual orientation, gender identity, disability status, protected veteran status, or any other characteristic protected by law.



  • Redwood City, California, United States C3 AI Full time

    C3 AI (NYSE: AI), is the Enterprise AI application software company. C3 AI delivers a family of fully integrated products including the C3 Agentic AI Platform, an end-to-end platform for developing, deploying, and operating enterprise AI applications, C3 AI applications, a portfolio of industry-specific SaaS enterprise AI applications that enable the digital...


  • Redwood City, California, United States Revolution Medicines Full time $256,000 - $320,000

    Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers.  The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment...


  • Redwood City, California, United States Soleno Therapeutics, Inc. Full time $230,000 - $260,000

    Summary of Job (brief description)The Medical Affairs Strategy Liaison is a hybrid role that will oversee Medical Affairs strategic activities with a focus on field medical needs for both internal company programs and external facing interactions. They will provide specialist medical & scientific strategic input into core medical affairs strategic and field...


  • Redwood City, California, United States Corcept Therapeutics Full time

    Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.In 2012, we received FDA approval of Korlym (mifepristone), the first approved treatment for hypercortisolism...


  • Redwood City, California, United States Allakos Full time

    Exec Director Regulatory Affairs/CMC   Allakos Inc. is a dynamic clinical-stage biopharmaceutical company developing first-in-class antibody-based therapeutics to treat allergic and inflammatory diseases.The Executive Director, CMC Regulatory Affairs is responsible for developing and directing the regulatory CMC strategy, objectives, and programs...


  • Culver City, California, United States Sony Full time

    Sony Corporation of America, located in New York, NY, is the U.S. headquarters of Sony Group Corporation, based in Tokyo, Japan. Sony's principal U.S. businesses include Sony Electronics Inc., Sony Interactive Entertainment LLC, Sony Music Entertainment, Sony Music Publishing and Sony Pictures Entertainment Inc. With some 900 million Sony devices in hands...


  • Redwood City, California, United States Revolution Medicines Full time

    Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers.  The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment...


  • Redwood City, California, United States Soleno Therapeutics, Inc. Full time

    About Soleno Therapeutics IncSoleno is a biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of rare diseases based in Redwood City, CA.At Soleno, we are driven by the unique and multi-faceted needs of the PWS community. Like these individuals, resilience is part of who we are – it is in our...


  • Redwood City, California, United States Revolution Medicines Full time

    Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers.  The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment...


  • Redwood City, California, United States Corcept Therapeutics Full time

    Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.In 2012, we received FDA approval of Korlym (mifepristone), the first approved treatment for hypercortisolism...